Using a more sophisticated approach to evaluating the tumor microenvironment in GI tumors 3 major groups including PD-L1 positive, myeloid suppression, and immune deserts can be identified that has major implications for the application of precision immunotherapy for this patient population. The gene discussed is CD274; the disease is neoplasm.